Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,091
Closed -$460K 724
2026
Q1
$460K Sell
6,091
-48,200
-89% -$3.62M ﹤0.01% 648
2025
Q4
$4.04M Sell
54,291
-7,244
-12% -$529K 0.04% 254
2025
Q3
$4.15M Hold
61,535
0.04% 234
2025
Q2
$4.01M Buy
61,535
+28,155
+84% +$1.69M 0.04% 228
2025
Q1
$2.06M Sell
33,380
-512
-2% -$33.9K 0.02% 351
2024
Q4
$2.44M Sell
33,892
-4,946
-13% -$386K 0.03% 327
2024
Q3
$3.16M Buy
38,838
+28,653
+281% +$2.29M 0.03% 286
2024
Q2
$756K Buy
10,185
+190
+2% +$14.2K 0.01% 571
2024
Q1
$779K Hold
9,995
0.01% 559
2023
Q4
$714K Buy
9,995
+909
+10% +$63.3K 0.01% 553
2023
Q3
$631K Buy
9,086
+558
+7% +$42.2K 0.01% 545
2023
Q2
$691K Hold
8,528
0.01% 542
2023
Q1
$688K Sell
8,528
-3,990
-32% -$321K 0.01% 499
2022
Q4
$936K Buy
12,518
+964
+8% +$68.7K 0.02% 442
2022
Q3
$745K Sell
11,554
-898
-7% -$62.2K 0.01% 480
2022
Q2
$863K Sell
12,452
-4,378
-26% -$325K 0.01% 471
2022
Q1
$1.29M Buy
16,830
+452
+3% +$32.5K 0.02% 430
2021
Q4
$1.25M Sell
16,378
-6,092
-27% -$448K 0.02% 401
2021
Q3
$1.66M Buy
22,470
+2,097
+10% +$157K 0.02% 349
2021
Q2
$1.36M Sell
20,373
-3,275
-14% -$219K 0.02% 368
2021
Q1
$1.76M Hold
23,648
0.03% 320
2020
Q4
$1.75M Buy
+23,648
New +$1.67M 0.03% 298

Other funds holding HOLX

B. Metzler seel. Sohn & Co's HOLX Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co sold out of Hologic (HOLX) in Q2 2026, closing a stake of 6,091 shares — an estimated $460K sold.

B. Metzler seel. Sohn & Co first reported a position in HOLX in Q4 2020 and held it in 22 quarters. The position peaked at $4.15M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • B. Metzler seel. Sohn & Co reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 6,091 Hologic shares in Q2 2026, an estimated $460K.
  • B. Metzler seel. Sohn & Co first reported a position in Hologic in Q4 2020 and held it in 22 quarters.
  • B. Metzler seel. Sohn & Co's Hologic position peaked at $4.15M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.